Home

DQ — Deck

Daqo New Energy · DQ · NYSE

Daqo New Energy manufactures high-purity polysilicon in China and sells it to solar wafer, cell, and module makers under spot-linked framework contracts.

$18.96
Price
$1.28B
Market cap
$568M
Revenue (TTM)
305k MT/yr
Polysilicon capacity
Listed Oct-2010 at $10.25; bottomed at $0.74 in Sep-2012, peaked at $124.13 in Feb-2021, now $18.96.
2 · The tension

Q1 turned Daqo into a sell-through test.

  • Production did not stop. Q1 2026 production was 43.4k MT, but sales were only 4.5k MT and revenue fell to $26.7M from $221.7M in Q4 2025.
  • Management chose price discipline. Daqo said market prices moved below production cost and it declined below-cost sales under Chinese self-regulation guidance; that turns policy enforcement into an earnings variable.
  • The proof is shipments at price. ASP nearly matched total cost at $5.96/kg versus $5.95/kg, but the quarter still produced a $139.4M gross loss after inventory provisions.
The next good quarter needs above-cost sell-through, not just above-cost quotes.
3 · Balance sheet

The cash pile buys time, but it is not free upside.

$2.0B
Q1 liquid assets zero debt
$1.28B
Market cap below cash-like assets
$270M
Q1 liquidity decline from Q4 2025
72.8%
Xinjiang Daqo owned subsidiary cash caveat

The bull case starts with a negative enterprise-value setup, but the value is not automatic. Liquid assets include fixed deposits and bank notes, and most operating assets sit under Xinjiang Daqo; the cash must either stop shrinking or show up through buybacks, dividends, or clean free cash flow.

4 · Unit economics

Book value only works if the plants earn above cost.

$5.25/kg
FY2025 ASP vs $6.61/kg cost
-20.7%
FY2025 gross margin same trough as 2024
-$123M
FY2025 free cash flow after capex
0.29x
Current P/B vs 0.63x 5Y mean

The stock is cheap on book because the market doubts the book can earn. Daqo built 305k MT/year of capacity, but at FY2025 pricing each kilogram lost money before corporate costs; a rerating needs ASP above full cost and utilization tied to actual shipments.

5 · Quality haircut

The cash-flow line needs a haircut.

  • Supplier notes carried CFO. FY2025 notes payable added $98.8M to operating cash flow; total CFO was $49.7M and free cash flow was -$123.3M.
  • Collections got noisier. FY2025 notes receivable rose 145.7% while revenue fell 35.3%, and DSO rose to 52.3 days from 30.4 days.
  • Governance is owner-led, not minority-led. Directors and officers own 36.1%, but Xiang Xu is chair and CEO, family members hold key roles, and newer $100M buyback authorizations were unused in FY2025.
Cash and book value deserve less than face value until they convert into shareholder cash.
6 · Proof window

The next six months can settle the debate.

  • June policy is the first soft test. Management pointed to cost-model and price-law enforcement around June 2026; formal above-cost mechanics matter more than repeated policy language.
  • Q2 is the operating test. A third-party calendar marks Aug. 25, 2026 as expected but not confirmed; watch sales versus the 35k-40k MT production guide, ASP, inventory charges, and cash-like assets.
  • The chart still votes no. The stock is $18.96, 27.1% below the $26.00 200-day average; a close above $26.00 repairs the tape, while below $18.03 reopens the $12.74 low.
Policy without transaction volume leaves Daqo choosing between idle capacity and below-cost sales.
7 · Bull and Bear

Lean watchlist — cash is not enough without sell-through.

  • For. $2.0B of Q1 liquid assets, zero debt, and a 0.29x book multiple leave room for a fast move if policy-backed prices let shipments normalize.
  • For. Daqo's Q1 cash cost was $4.59/kg, below the $5.96/kg ASP, so small price gains can restore operating leverage if volumes return.
  • Against. Q1 sales were 4.5k MT against 43.4k MT of production, and the quarter still carried a $139.4M gross loss after inventory provisions.
  • Against. FY2025 positive CFO depended on $98.8M of notes-payable support; free cash flow remained -$123.3M and newer buyback authorizations sat unused.
My view: watchlist, not long, until Daqo ships near production at ASP above full cost. The flip condition is one quarter with sales within 10% of production, no new inventory or asset charge, and positive CFO after notes payable normalizes.

Watchlist to re-rate: June 2026 policy-cost guidance; Q2/Q3 2026 sales volume versus production and ASP versus full cost; liquidity bridge, notes payable, and actual repurchases.